[1. Gazdic M, Volarevic V, Arsenijevic N, Stojkovic M. Mesenchymal stem cells: a friend or foe in immune-mediated diseases. Stem Cell Rev 2015;11:280-287.10.1007/s12015-014-9583-325592610]Search in Google Scholar
[2. Volarevic V, Ljujic B, Stojkovic P, Lukic A, Arsenijevic N, Stojkovic M. Human stem cell research and regenerative medicine-present and future. Br Med Bull 2011;99:155-168.10.1093/bmb/ldr02721669982]Search in Google Scholar
[3. Volarevic V, Gazdic M, Simovic Markovic B, Jovicic N, Djonov V, Arsenijevic N. Mesenchymal stem cell-derived factors: Immunomodulatory effects and therapeutic potential. Biofactors 2017;43:633-644.10.1002/biof.137428718997]Open DOISearch in Google Scholar
[4. Volarevic V, Al-Qahtani A, Arsenijevic N, Pajovic S, Lukic ML. Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis. Autoimmunity 2010;43:255-263.10.3109/0891693090330564119845478]Search in Google Scholar
[5. Carraro G, Perin L, Sedrakyan S, Giuliani S, Tiozzo C, Lee J, Turcatel G, De Langhe SP, Driscoll B, Bellusci S, Minoo P, Atala A, De Filippo RE, Warburton D. Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells 2008;26:2902-2911.1871922610.1634/stemcells.2008-0090317410518719226]Search in Google Scholar
[6. Moorefield EC, McKee EE, Solchaga L, Orlando G, Yoo JJ, Walker S, Furth ME, Bishop CE. Cloned, CD117 selected human amniotic fluid stem cells are capable of modulating the immune response. PLoS One 2011;6:e26535.10.1371/journal.pone.0026535320254322046303]Search in Google Scholar
[7. Deng J, Petersen BE, Steindler DA, Jorgensen ML, Laywell ED. Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation. Stem Cells 2006; 24:1054-1064.10.1634/stemcells.2005-037016322639]Open DOISearch in Google Scholar
[8. Yan ZJ, Hu YQ, Zhang HT, Zhang P, Xiao ZY, Sun XL, Cai YQ, Hu CC, Xu RX. Comparison of the neural differentiation potential of human mesenchymal stem cells from amniotic fluid and adult bone marrow. Cell Mol Neurobiol 2013;33:465-475.2347894010.1007/s10571-013-9922-y23478940]Search in Google Scholar
[9. Farzaneh M, Rahimi F, Alishahi M, Khoshnam SE. Paracrine mechanisms involved in mesenchymal stem cell differentiation into cardiomyocytes. Curr Stem Cell Res Ther 2018 Aug 21. doi: 10.2174/1574888X13666180821160421.10.2174/1574888X1366618082116042130152289]Open DOISearch in Google Scholar
[10. Zheng YB, Gao ZL, Xie C, Zhu HP, Peng L, Chen JH, Chong YT. Characterization and hepatogenic differentiation of mesenchymal stem cells from human amniotic fluid and human bone marrow: A comparative study. Cell Biol Int 2008;32:143-1448.10.1016/j.cellbi.2008.08.01518782626]Search in Google Scholar
[11. Wu Q, Tang J, Li Y, Li L, Wang Y, Bao J, Bu H. Hepatic differentiation of mouse bone marrow-derived mesenchymal stem cells using a novel 3D culture system. Mol Med Rep 2017;16:9473-9479.10.3892/mmr.2017.7818578000529152658]Open DOISearch in Google Scholar
[12. Huang K, Kang X, Wang X, Wu S, Xiao J, Li Z, Wu X, Zhang W. Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats. Mol Med Rep 2015;11:1685-1692.10.3892/mmr.2014.2981427032425411925]Search in Google Scholar
[13. Gong X, Sun Z, Cui D, Xu X, Zhu H, Wang L, Qian W, Han X. Isolation and characterization of lung resident mesenchymal stem cells capable of differentiating into alveolar epithelial type II cells. Cell Biol Int 2014;38:405-411.10.1002/cbin.1024024403246]Open DOISearch in Google Scholar
[14. Xie QP, Huang H, Xu B, Dong X, Gao SL, Zhang B, Wu YL. Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon micro-environmental manipulation in vitro. Differentiation 2009;77:483-491.10.1016/j.diff.2009.01.00119505629]Search in Google Scholar
[15. Li YW, Zhang C, Sheng QJ, Bai H, Ding Y, Dou XG. Mesenchymal stem cells rescue acute hepatic failure by polarizing M2 macrophages. World J Gastroenterol 2017;23:7978-7988.10.3748/wjg.v23.i45.7978572529229259373]Open DOISearch in Google Scholar
[16. Guan XJ, Song L, Han FF, Cui ZL, Chen X, Guo XJ, Xu WG. Mesenchymal stem cells protect cigarette smoke-damaged lung and pulmonary function partly via VEGFVEGF receptors. J Cell Biochem 2013;114:323-335.10.1002/jcb.2437722949406]Search in Google Scholar
[17. Pandey AC, Lancaster JJ, Harris DT, Goldman S, Juneman E. Cellular Therapeutics for Heart Failure: Focus on Mesenchymal Stem Cells. Stem Cells Int 2017;2017:9640108.10.1155/2017/9640108574811029391871]Search in Google Scholar
[18. Di Trapani M, Bassi G, Ricciardi M, Fontana E, Bifari F, Pacelli L, Giacomello L, Pozzobon M, Féron F, De Coppi P, Anversa P, Fumagalli G, Decimo I, Menard C, Tarte K, Krampera M. Comparative study of immune regulatory properties of stem cells derived from different tissues. Stem Cells Dev 2013;22:2990e3002.10.1089/scd.2013.0204384047323819720]Open DOISearch in Google Scholar
[19. Kode JA, Mukherjee S, Joglekar MV, Hardikar AA. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 2009;11:377e91.10.1080/1465324090308036719568970]Search in Google Scholar
[20. Tao H, Han Z, Han ZC, Li Z. Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications. Stem Cells Int 2016;2016:1314709.10.1155/2016/1314709473681626880933]Search in Google Scholar
[21. Harrell CR, Simovic Markovic B, Fellabaum C, Arsenijevic A, Djonov V, Arsenijevic N, Volarevic V. Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Eye Diseases. Adv Exp Med Biol 2018 May 18. doi: 10.1007/5584_2018_219.10.1007/5584_2018_21929774506]Open DOISearch in Google Scholar
[22. Hyenne V, Apaydin A, Rodriguez D, Spiegelhalter C, Hoff-Yoessle S, Diem M, Tak S, Lefebvre O, Schwab Y, Goetz JG, Labouesse M. RAL-1 controls multivesicular body biogenesis and exosome secretion. J Cell Biol 2015;211:27-37.10.1083/jcb.201504136460204026459596]Search in Google Scholar
[23. Hass R, Kasper C, Böhm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 2011;9:12.10.1186/1478-811X-9-12311782021569606]Search in Google Scholar
[24. Kil K, Choi MY, Kong JS, Kim WJ, Park KH. Regenerative efficacy of mesenchymal stromal cells from human placenta in sensorineural hearing loss. Int J Pediatr Otorhinolaryngol 2016;91:72-81.10.1016/j.ijporl.2016.10.01027863646]Search in Google Scholar
[25. Cho JS, Lee J, Jeong DU, Kim HW, Chang WS, Moon J, Chang JW. Effect of Placenta-Derived Mesenchymal Stem Cells in a Dementia Rat Model via Microglial Mediation: a Comparison between Stem Cell Transplant Methods. Yonsei Med J 2018;59:406-415.10.3349/ymj.2018.59.3.406588999329611403]Search in Google Scholar
[26. Jiang H, Zhang Y, Tian K, Wang B, Han S. Amelioration of experimental autoimmune encephalomyelitis through transplantation of placental derived mesenchymal stem cells. Sci Rep 2017;7:41837.10.1038/srep41837530125628186117]Search in Google Scholar
[27. Moore MC, Van De Walle A, Chang J, Juran C, McFetridge PS. Human Perinatal-Derived Biomaterials. Adv Healthc Mater 2017;6(18).10.1002/adhm.201700345573369228783879]Search in Google Scholar
[28. Farmer D. Placental stem cells: The promise of curing diseases before birth. Placenta 2017;59:113-115.10.1016/j.placenta.2017.04.02228477969]Search in Google Scholar
[29. Abumaree MH, Abomaray FM, Alshabibi MA, AlAskar AS, Kalionis B. Immunomodulatory properties of human placental mesenchymal stem/stromal cells. Placenta 2017;59:87-95.10.1016/j.placenta.2017.04.00328411943]Search in Google Scholar
[30. Xu Q, Resch MG, Podkaminer K, Yang S, Baker JO, Donohoe BS, Wilson C, Klingeman DM, Olson DG, Decker SR, Giannone RJ, Hettich RL, Brown SD, Lynd LR, Bayer EA, Himmel ME, Bomble YJ. Dramatic performance of Clostridium thermocellum explained by its wide range of cellulase modalities. Sci Adv 2016;2:e1501254.10.1126/sciadv.1501254478847826989779]Search in Google Scholar
[31. Xu F, Yi J, Wang Z, Hu Y, Han C, Xue Q, Zhang X, Luan X. IL-27 regulates the adherence, proliferation, and migration of MSCs and enhances their regulatory effects on Th1 and Th2 subset generations. Immunol Res 2017;65:903-912.10.1007/s12026-017-8929-8554478028612255]Open DOISearch in Google Scholar
[32. Sordi V, Malosio ML, Marchesi F, Mercalli A, Melzi R, Giordano T, Belmonte N, Ferrari G, Leone BE, Bertuzzi F, Zerbini G, Allavena P, Bonifacio E, Piemonti L. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005;106:419-427.10.1182/blood-2004-09-350715784733]Search in Google Scholar
[33. Yoshida R, Nagira M, Kitaura M, Imagawa N, Imai T, Yoshie O. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. J Biol Chem 1998;273:7118-71122.10.1074/jbc.273.12.71189507024]Search in Google Scholar
[34. Hocking AM. The Role of Chemokines in Mesenchymal Stem Cell Homing to Wounds. Adv Wound Care (New Rochelle) 2015;4:623-630.10.1089/wound.2014.0579462051826543676]Search in Google Scholar
[35. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by trans-differentiation into multiple skin cell type. J Immunol 2008;180:2581.10.4049/jimmunol.180.4.258118250469]Search in Google Scholar
[36. Xu B, Aoyama K, Kusumoto M, Matsuzawa A, Butcher EC, Michie SA, Matsuyama T, Takeuchi T. Lack of lymphoid chemokines CCL19 and CCL21 enhances allergic airway inflammation in mice. Int Immunol 2007;19:775-84.10.1093/intimm/dxm0461751387917513879]Open DOISearch in Google Scholar
[37. Liu J, Wei Y, Luo Q, Xu F, Zhao Z, Zhang H, Lu L, Sun J, Liu F, Du X, Li M, Wei K, Dong J. Baicalin attenuates inflammation in mice with OVA-induced asthma by inhibiting NF-κB and suppressing CCR7/CCL19/CCL21. Int J Mol Med 2016;38:1541-1548.10.3892/ijmm.2016.274327666000]Open DOISearch in Google Scholar
[38. Jin Y, Shen L, Chong EM, Hamrah P, Zhang Q, Chen L, Dana MR. The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking. Mol Vis 2007;13:626-34.17515886]Search in Google Scholar
[39. De Pascale MR, Sommese L, Casamassimi A, Napoli C. Platelet derivatives in regenerative medicine: an update. Transfus Med Rev 2015;29:52-61.10.1016/j.tmrv.2014.11.00125544600]Search in Google Scholar
[40. Hayashi Y, Murakami M, Kawamura R, Ishizaka R, Fukuta O, Nakashima M. CXCL14 and MCP1 are potent trophic factors associated with cell migration and angiogenesis leading to higher regenerative potential of dental pulp side population cells. Stem Cell Res Ther 2015;6:111.10.1186/s13287-015-0088-z448805926021377]Search in Google Scholar
[41. Kuhn EN, Wu SM. Origin of cardiac progenitor cells in the developing and postnatal heart. J Cell Physiol20568226]Search in Google Scholar
[42. Chen HW, Chen HY, Wang LT, Wang FH, Fang LW, Lai HY, Chen HH, Lu J, Hung MS, Cheng Y, Chen MY, Liu SJ, Chong P, Lee OK, Hsu SC. Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines. J Immunol 2013;190:5065-77.10.4049/jimmunol.120277523589610]Search in Google Scholar
[43. Okuyama H, Krishnamachary B, Zhou YF, Nagasawa H, Bosch-Marce M, Semenza GL. Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxiainducible factor 1. J Biol Chem 2006;281:15554-15563.10.1074/jbc.M60200320016574650]Search in Google Scholar
[44. Hercus TR, Thomas D, Guthridge MA, Ekert PG, King-Scott J, Parker MW, Lopez AF. The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease. Blood 2009;114:1289-1298.10.1182/blood-2008-12-164004272741619436055]Search in Google Scholar
[45. Srivastava M, Ahlawat N, Srivastava A. Amniotic Fluid Stem Cells: A New Era in Regenerative Medicine. J Obstet Gynaecol India 2018;68:15-19.10.1007/s13224-017-1034-z578389929391670]Search in Google Scholar
[46. Loukogeorgakis SP, De Coppi P. Stem cells from amniotic fluid--Potential for regenerative medicine. Best]Search in Google Scholar
[47. Volarevic V, Markovic BS, Gazdic M, Volarevic A, Jovicic N, Arsenijevic N, Armstrong L, Djonov V, Lako M, Stojkovic M. Ethical and Safety Issues of Stem Cell-Based Therapy. Int J Med Sci 2018;15:36-45.10.7150/ijms.21666576573829333086]Search in Google Scholar
[48. Breitbach M, Bostani T, Roell W, Xia Y, Dewald O, Nygren JM, Fries JW, Tiemann K, Bohlen H, Hescheler J, Welz A, Bloch W, Jacobsen SE, Fleischmann BK. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007;110:1362-1369.10.1182/blood-2006-12-06341217483296]Search in Google Scholar
[49. Yoon YS, Park JS, Tkebuchava T, Luedeman C, Losordo DW. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 2004;109:3154-157.10.1161/01.CIR.0000134696.08436.6515197139]Search in Google Scholar
[50. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A 2007; 104:11002-11007.10.1073/pnas.0704421104189181317569781]Search in Google Scholar
[51. Day C, Patel R, Guillen C, Wardlaw AJ. The chemokine CXCL16 is highly and constitutively expressed by human bronchial epithelial cells. Exp Lung Res 2009; 35:272-283.10.1080/01902140802635517268563919415545]Open DOISearch in Google Scholar
[52. Morgan AJ, Guillen C, Symon FA, Huynh TT, Berry MA, Entwisle JJ, Briskin M, Pavord ID, Wardlaw AJ. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease. Clin Exp Allergy 2005; 35:1572-1580.10.1111/j.1365-2222.2005.02383.x16393323]Open DOISearch in Google Scholar
[53. Huang L, Zhang L, Ju H, Li Q, Pan JS, Al-Lawati Z, Sheikh-Hamad D. Stanniocalcin-1 inhibits thrombin-induced signaling and protects from bleomycin-induced lung injury. Sci Rep 2015;5:18117.10.1038/srep18117467114726640170]Search in Google Scholar
[54. Nanki T, Shimaoka T, Hayashida K, Taniguchi K, Yonehara S, Miyasaka N. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. Arthritis Rheum 2005;52:3004-3014.10.1002/art.2130116200580]Open DOISearch in Google Scholar
[55. Rump L, Mattey DL, Kehoe O, Middleton J. An initial investigation into endothelial CC chemokine expression in the human rheumatoid synovium. Cytokine 2017;97:133-140.10.1016/j.cyto.2017.05.023551677328648867]Search in Google Scholar
[56. Jin Y, Shen L, Chong EM, Hamrah P, Zhang Q, Chen L, Dana MR. The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking. Mol Vis 2007;13:626-634.17515886]Search in Google Scholar
[57. Shaykhiev R, Sackrowitz R, Fukui T, Zuo WL, Chao IW, Strulovici-Barel Y, Downey RJ, Crystal RG. Smoking-induced CXCL14 expression in the human airway epithelium links chronic obstructive pulmonary disease to lung cancer. Am J Respir Cell Mol Biol 2013;49:418-425.10.1165/rcmb.2012-0396OC382405223597004]Search in Google Scholar
[58. Zaidi N, Nixon AJ. Stem cell therapy in bone repair and regeneration. Ann N Y Acad Sci 2007;1117:62-72.10.1196/annals.1402.07418056038]Open DOISearch in Google Scholar
[59. Hu K, Olsen BR. The roles of vascular endothelial growth factor in bone repair and regeneration. Bone 2016;91:30-38.10.1016/j.bone.2016.06.013499670127353702]Search in Google Scholar
[60. Clarkin CE, Gerstenfeld LC. VEGF and bone cell signalling: an essential vessel for communication? Cell Biochem Funct 2013;31:1-11.10.1002/cbf.29112312928923129289]Open DOISearch in Google Scholar
[61. Huang H, Shen J, Vinores SA. Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye. PLoS One 2011; 6:e21411.10.1371/journal.pone.0021411312088221731737]Search in Google Scholar
[62. Hasegawa E, Oshima Y, Takeda A, Saeki K, Yoshida H, Sonoda KH, Ishibashi T. IL-27 inhibits pathophysiological intraocular neovascularization due to laser burn. J Leukoc Biol 2012;91:267-273.10.1189/jlb.111060322045869]Search in Google Scholar
[63. Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, Gery I, Lee YS, Egwuagu CE. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 2007;13:711-718.10.1038/nm158517496900]Search in Google Scholar
[64. Shi G, Field DJ, Ko KA, Ture S, Srivastava K, Levy S, Kowalska MA, Poncz M, Fowell DJ, Morrell CN. Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection. J Clin Invest 2014;124:543-552.10.1172/JCI71858390462424463452]Search in Google Scholar
[65. Yu B, Zhang X, Li X. Exosomes derived from mesenchymal stem cells. Int J Mol Sci 2014;15:4142-4157.2460892610.3390/ijms15034142]Search in Google Scholar
[66. Cruz FF, Rocco PRM. Stem-cell extracellular vesicles and lung repair. Stem Cell Investig 2017;4:78.10.21037/sci.2017.09.02]Search in Google Scholar
[67. Yamada J, Dana MR, Sotozono C, Kinoshita S. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Exp Eye Res 2003;76:161-167.10.1016/S0014-4835(02)00293-2]Search in Google Scholar